News

Deal Announcements

Accuri Accumulates $13 Million Series C Funding

Wednesday, July 9, 2008 5:49:00 AM PDT | VentureDeal Staff
Ann Arbor, Michigan -- Medical device company Accuri Cytometers announced that it has closed its third round of venture capital funding, receiving $13 million in new investment.

The company is developing high-performance cell analysis systems utilizing flow cytometry technologies to help researchers develop protocols and reagents for use in their research.

The investor syndicate was made up of Fidelity Biosciences, Baird Venture Partners, Flagship Ventures and Arboretum Ventures.  The company said it would use the proceeds from the financing to expand commercialization activities for its Accuri C6 Flow Cytometer System.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1